annb0t
Top 20
Revenue: Increased by 12% to $1,162.8 million in Q2 FY2024 compared to the same period last year. Net Income: Reported at $208.8 million, a 7% decrease from the prior year's quarter. Non-GAAP Measures: Non-GAAP net income rose by 13% to $277.3 million, with non-GAAP diluted earnings per share up by 13% to $1.88. Gross Margin: Slight decrease to 55.6% from 56.1% in the prior year period. Dividend: A quarterly cash dividend of $0.48 per share announced, payable on March 14, 2024. Operational Excel...
>>> Read more: ResMed Inc (RMD) Reports Solid Revenue Growth in Q2 FY2024 Amidst Expanding Global Market Presence
>>> Read more: ResMed Inc (RMD) Reports Solid Revenue Growth in Q2 FY2024 Amidst Expanding Global Market Presence
